Treatments

In China, vaccine hesitancy lingers even as COVID cases surge

Tue, 2023-01-03 13:40 — mike kraft

'I don't trust it:' Vaccine hesitancy lingers even as China COVID cases surge The problem is a growing headache for Beijing as it tries to persuade more people to get vaccinated in the face of a spike in infections and the prospect of more than 1.5 million deaths after the lifting of strict anti-COVID measures. David Kirton Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about In China, vaccine hesitancy lingers even as COVID cases surge
Log in or register to post comments

COVID booster prompts good immune response, except after recent infection --study

Tue, 2023-01-03 12:50 — mike kraft

COVID booster prompts good immune response, except after recent infection CIDRAP

A study today in Clinical Infectious Diseases finds that a third COVID-19 vaccine dose triggered a robust immune response, regardless of whether recipients had been infected more than 3 months earlier, but it didn't significantly increase antibody levels in those infected less than 3 months before.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about COVID booster prompts good immune response, except after recent infection --study
Log in or register to post comments

China, EU in dispute over China's COVID crisis, Beijing threatens countermeasures

Tue, 2023-01-03 10:07 — mike kraft

EU, Beijing heading for collision over China's COVID crisis BRUSSELS (AP) — The European Union and China on Tuesday moved closer to a political standoff over the COVID-19 crisis, with Beijing vehemently rejecting travel restrictions some EU nations have started to impose that could well be expanded in coming days. AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about China, EU in dispute over China's COVID crisis, Beijing threatens countermeasures
Log in or register to post comments

A promising new Covid pill shows key advantages over Paxlovid in trial

Thu, 2022-12-29 22:10 — FNUOvviyaa

A promising new Covid pill shows key advantages over Paxlovid in trial A Chinese antiviral pill was found to be as effective as Paxlovid in a Phase 3 trial, and it appeared to cause fewer side effects. NBC News

...

"You have a medication that looks to be just as good as Paxlovid, but less cumbersome," said Dr. Panagis Galiatsatos, an assistant professor of medicine at Johns Hopkins Medicine in Baltimore.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about A promising new Covid pill shows key advantages over Paxlovid in trial
Log in or register to post comments

COVID Smell Loss: 'Retraining' Mostly Flops in Trial

Thu, 2022-12-29 21:48 — FNUOvviyaa

COVID Smell Loss: 'Retraining' Mostly Flops in Trial Some patients did recover olfactory function with two-prong therapy, however Kate Kneisel medpagetoday

...

Bimodal olfactory training with visual cues and the use of patient-preferred scents did not produce a clinically meaningful improvement in sense of smell among individuals with COVID-19–related olfactory loss, a 275-patient randomized trial showed.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about COVID Smell Loss: 'Retraining' Mostly Flops in Trial
Log in or register to post comments

Long COVID: What scientists have learned about the symptoms affecting millions around the world

Mon, 2022-12-26 17:19 — FNUOvviyaa

Long COVID: What scientists have learned about the symptoms affecting millions around the world A British historian, an Italian archaeologist and an American preschool teacher each helped bring long COVID into the public's consciousness. CBS News

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Long COVID: What scientists have learned about the symptoms affecting millions around the world
Log in or register to post comments

China's COVID cases overwhelm hospitals

Mon, 2022-12-26 16:59 — FNUOvviyaa

China's COVID cases overwhelm hospitals In more than three decades of emergency medicine, Beijing-based doctor Howard Bernstein said, he has never seen anything like this. Martin Quin Pollard Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Read more about China's COVID cases overwhelm hospitals
Log in or register to post comments

BioNTech starts human trial to test malaria vaccine

Fri, 2022-12-23 22:04 — FNUOvviyaa

BioNTech starts human trial to test malaria vaccine BioNTech on Friday initiated an early-stage study to evaluate its experimental malaria vaccine in humans, the German drugmaker said. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about BioNTech starts human trial to test malaria vaccine
Log in or register to post comments

Uganda gets Ebola vaccine doses for trial on Sudan strain

Thu, 2022-12-22 19:15 — FNUOvviyaa

Uganda gets Ebola vaccine doses for trial on Sudan strain KAMPALA, Uganda (AP) — Uganda’s government says it has received more than 5,000 doses of Ebola vaccines for a clinical trial to assess their protection against the Sudan strain of the virus that caused an outbreak with over 50 deaths. AP NEWS

...

This outbreak, the first in a decade of the less common Sudan strain, is a chance for clinical trials of the three vaccines donated by the U.S.-based Sabin Vaccine Institute, University of Oxford and Merck.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis